null
Click on the links below to see details of all the cancer service guidance, published or in development, in this topic area.
Completed cancer service guidance
Click on the links below to see details of all the clinical guidelines, published or in development, in this topic area.
Completed guidelines
Guidelines in development
- None
Click on the links below to see details of all the interventional procedures, published or in development, in this topic area.
Completed interventional procedures
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision
Endoscopic axillary lymph node retrieval for breast cancer
Endoscopic mastectomy and endoscopic wide local excision for breast cancer
Image-guided radiofrequency excision biopsy of breast lesions
Interstitial laser therapy for breast cancer
Interventional procedures in development
- None
Click on the links below to see details of all the technology appraisals, published or in development, in this topic area.
Completed appraisals
Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal)
Breast cancer (early) - docetaxel
Breast cancer (early) - hormonal treatments
Breast cancer (early) - paclitaxel
Breast cancer (early) - trastuzumab
Breast cancer - capecitabine (replaced by CG81)
Breast cancer - gemcitabine
Breast cancer - taxanes (review)(replaced by CG81)
Breast cancer - trastuzumab
Breast cancer - vinorelbine (replaced by CG81)
Appraisals in development
Bone loss (therapy-induced) in non-metastatic breast cancer - denosumab
Breast cancer (advanced and/or metastatic) - sunitinib (in combination with capecitabine)
Breast cancer (advanced or metastatic) - lapatinib
Breast cancer (advanced or metastatic) hormone-sensitive - lapatinib
Breast cancer (first line) - bevacizumab
Breast cancer (locally advanced or metastatic) - ixabepilone
Breast cancer - bevacizumab (in combination with a taxane)
Breast cancer - intensity modulated radiotherapy (suspended)